首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 9,12,21,24-四(4-氨基丁基)-15,18-二仲丁基-33-(2-羧乙基)-6-(4-羟基苄基)-36-(羟甲基)-3,27,30-三异丁基-1,4,7,10,13,16,19,22,25,28,31,34-十二氧代-1-(吡咯烷-2-基)-2,5,8,11,14,17,20,23,26,29,32,35-十二氮杂庚三十七烷-37-酸

9,12,21,24-四(4-氨基丁基)-15,18-二仲丁基-33-(2-羧乙基)-6-(4-羟基苄基)-36-(羟甲基)-3,27,30-三异丁基-1,4,7,10,13,16,19,22,25,28,31,34-十二氧代-1-(吡咯烷-2-基)-2,5,8,11,14,17,20,23,26,29,32,35-十二氮杂庚三十七烷-37-酸

9,12,21,24-tetrakis(4-aminobutyl)-15,18-di-sec-butyl-33-(2-carboxyethyl)-6-(4-hydroxybenzyl)-36-(hydroxymethyl)-3,27,30-triisobutyl-1,4,7,10,13,16,19,22,25,28,31,34-dodecaoxo-1-(pyrrolidin-2-yl)-2,5,8,11,14,17,20,23,26,29,32,35-dodecaazaheptatriacontan-37-oic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

82989-21-7

中文名称

9,12,21,24-四(4-氨基丁基)-15,18-二仲丁基-33-(2-羧乙基)-6-(4-羟基苄基)-36-(羟甲基)-3,27,30-三异丁基-1,4,7,10,13,16,19,22,25,28,31,34-十二氧代-1-(吡咯烷-2-基)-2,5,8,11,14,17,20,23,26,29,32,35-十二氮杂庚三十七烷-37-酸

英文名称

9,12,21,24-tetrakis(4-aminobutyl)-15,18-di-sec-butyl-33-(2-carboxyethyl)-6-(4-hydroxybenzyl)-36-(hydroxymethyl)-3,27,30-triisobutyl-1,4,7,10,13,16,19,22,25,28,31,34-dodecaoxo-1-(pyrrolidin-2-yl)-2,5,8,11,14,17,20,23,26,29,32,35-dodecaazaheptatriacontan-37-oic acid

别名

H-PRO-LEU-TYR-LYS-LYS-ILE-ILE-LYS-LYS-LEU-LEU-GLU-SER-OH;platelet factor 4 fragment 58-70 human;PF4 (58-70) (HUMAN);PLATELET FACTOR 4 (58-70) (HUMAN);PLATELET FACTOR-4 (HUMAN, 58-70);PRO-LEU-TYR-LYS-LYS-ILE-ILE-LYS-LYS-LEU-LEU-GLU-SER;L-Prolyl-L-leucyl-L-tyrosyl-L-lysyl-L-lysyl-L-isoleucyl-L-isoleucyl-L-lysyl-L-lysyl-L-leucyl-L-leucyl-L-α-glutamyl-L-serine;PLATELET FACTOR 4 (58-70) (HUMAN) USP/EP/BP

标准英文名

9,12,21,24-tetrakis(4-aminobutyl)-15,18-di-sec-butyl-33-(2-carboxyethyl)-6-(4-hydroxybenzyl)-36-(hydroxymethyl)-3,27,30-triisobutyl-1,4,7,10,13,16,19,22,25,28,31,34-dodecaoxo-1-(pyrrolidin-2-yl)-2,5,8,11,14,17,20,23,26,29,32,35-dodecaazaheptatriacontan-37-oic acid

MDL No.

MFCD00237228

分子式

C76H133N17O18

分子量

1573.00

精确分子量

1572.00

SMILES

CCC(C)C(NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(C)C)NC(=O)C1CCCN1)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)O)C(C)CC

标准SMILES

CC(CC)C(NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC1C=CC(O)=CC=1)NC(=O)C(CC(C)C)NC(=O)C1CCCN1)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CO)C(O)=O

用途

Contains the major heparin-binding domain of platelet factor 4 (PF4); insufficient for full anti-angiogenic activity.

InChIKey

SACBPCXTLNEHGC-UHFFFAOYSA-N

安全信息

SureRoute逆合成路线

1.  82989-21-7 逆合成路线 1

—
—
ACQUOU930
82989-21-7
来源: SureRoute

2.  82989-21-7 逆合成路线 2

—
—
ACQUOU930
82989-21-7
来源: SureRoute

3.  82989-21-7 逆合成路线 3

—
—
ACQUOU930
82989-21-7
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手